Hans-Roland Dürr

17PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsTumour immunologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial.

|Feb 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched Analysis.

Luc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier

|Nov 26, 2024
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions.

Tina Frankenbach-Désor, Isabella Niesner, Parveen Ahmed

|May 25, 2024
Unplanned Resections of Soft Tissue Sarcomas-Necessity of Re-Resection?

Julian Fromm, Alexander Klein, Franziska Mentrup

|Jan 23, 2024
Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk.

Franziska Mentrup, Alexander Klein, Lars Hartwin Lindner

|Jun 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS).

Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner

Pageof 3

Frequent Collaborators

9 joint publications

Lars Hartwin Lindner

7 joint publications

Markus Albertsmeier

7 joint publications

Thomas Knösel

6 joint publications

Alexander Klein